PREVENTION OF CHRONIC REJECTION IN MOUSE AORTIC ALLOGRAFTS BY COMBINED TREATMENT WITH CTLA4-Ig AND ANTI-CD40 LIGAND MONOCLONAL ANTIBODY1,2-Reference-Cited by-同舟云学术

PREVENTION OF CHRONIC REJECTION IN MOUSE AORTIC ALLOGRAFTS BY COMBINED TREATMENT WITH CTLA4-Ig AND ANTI-CD40 LIGAND MONOCLONAL ANTIBODY1,2

Published:1997-12 Issue:12 Volume:64 Page:1838-1843
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Sun Hong,Subbotin Vladimir,Chen Christopher,Aitouche Abdelouahab,Valdivia Luis A.,Sayegh Mohammed H.,Linsley Peter S.,Fung John J.,Starzl Thomas E.,Rao Abdul S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference11 articles.

1. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion.

2. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.

3. TRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1

4. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.

5. CD28-B7 T CELL COSTIMULATORY BLOCKADE BY CTLA4Ig IN THE RAT RENAL ALLOGRAFT MODEL1,2

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection;Immunology Letters;2024-06

2. Exploring Costimulatory Blockade-Based Immunologic Strategies in Transplantation: Are They a Promising Immunomodulatory Approach for Organ and Vascularized Composite Allotransplantation?;Journal of Personalized Medicine;2024-03-20

3. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation;Journal of Vascular Research;2019

4. Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules;Medicinal Research Reviews;2018-09-14

5. Immune-Mediated Vascular Injury and Dysfunction in Transplant Arteriosclerosis;Frontiers in Immunology;2015-01-12